Cancer is a great equalizer; it does not differentiate between rich or poor, young or old. The history of cancer is as ancient as the origins of humans and continues to be an enigma in the 21st century. Much has been uncovered about the causes of various cancers, and tremendous advances in both diagnostics and therapeutics have occurred. Indeed, patients with cancer today are living longer and with a better quality of life, and the horizon looks even more promising. However, one supposedly rare neoplastic condition called neuroendocrine tumor (NET) is often ceded to obscurity by academia, the pharmaceutical industry, health care policy makers, and media. Although celebrities, including Steve Jobs and Aretha Franklin, have received diagnoses of NET, public awareness about this condition has been lacking.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Chauhan A, Kohn E, Del Rivero J. Neuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence. JAMA Oncol. Published online November 07, 2019. doi:https://doi.org/10.1001/jamaoncol.2019.4568
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: